Top 3 Tips for Choosing the Right Oncology CRO
The decision to partner with a Clinical Research Organization (CRO) is never taken...
Ensuring Patient Safety and Data Integrity with Veristat’s DMC Expertise
Data Monitoring Committees (DMCs) play a vital role in clinical trials by providing independent...
FDA Delays Push Biotech Companies to Rethink U.S. Drug Development Strategy
A growing number of biotech firms are questioning their long-standing strategy of initiating...
Bayesian Study Designs in Early-Phase Oncology Trials
The development of innovative oncology therapies has evolved dramatically, moving beyond...
Monthly FDA Guidance and Regulatory News Review - April 2025
Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance...
Staying the Course: What FDA Staffing Reductions Mean for Drug Development Today
The U.S. Food and Drug Administration (FDA) is undergoing significant change. Recent announcements...
Unlocking the Promise of Radiopharmaceuticals: Safety, Strategy & Innovation in Clinical Trials
We’re hearing more and more about the value of radiopharmaceuticals in medicine today—but what does...
Building Confidence in RWE: Delivering Smarter Regulatory Strategies
Real-world evidence (RWE) offers the potential to serve as a valuable tool in regulatory...
The Evolving Landscape of Radiopharmaceuticals in Oncology Research
Radiopharmaceuticals have been around for decades, but their role in oncology is expanding rapidly....
Monthly FDA Guidance and Regulatory News Review - March 2025
Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance...